Johnson John Paul has filed 11 insider transactions across 1 company since February 2024.
Most recent transaction: a grant/award of 25461 shares of Evolent Health, Inc. ($EVH) on July 01, 2025.
Activity breakdown: 0 open-market purchases and 1 sale.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| July 1, 2025 | Evolent Health, Inc. | $EVH | Johnson John Paul | Chief Financial Officer | A | Class A Common Stock | 25461 | $0.00 | 309,245.0000 | 116,591,148 | 8.97% | 0.02% |
| March 1, 2025 | Evolent Health, Inc. | $EVH | Johnson John Paul | Chief Financial Officer | F | Class A Common Stock | 9246 | $8.99 | 161,961.0000 | 116,591,148 | 5.40% | 0.01% |
| March 3, 2025 | Evolent Health, Inc. | $EVH | Johnson John Paul | Chief Financial Officer | A | Class A Common Stock | 89113 | $0.00 | 251,074.0000 | 116,591,148 | 55.02% | 0.08% |
| March 3, 2025 | Evolent Health, Inc. | $EVH | Johnson John Paul | Chief Financial Officer | A | Class A Common Stock | 59582 | $0.00 | 310,656.0000 | 116,591,148 | 23.73% | 0.05% |
| March 3, 2025 | Evolent Health, Inc. | $EVH | Johnson John Paul | Chief Financial Officer | F | Class A Common Stock | 26872 | $8.77 | 283,784.0000 | 116,591,148 | 8.65% | 0.02% |
| Aug. 22, 2024 | Evolent Health, Inc. | $EVH | Johnson John Paul | Chief Financial Officer | S | Class A Common Stock | 44693 | $30.00 | 171,207.0000 | 0 | 20.70% | 0.00% |
| March 1, 2024 | Evolent Health, Inc. | $EVH | Johnson John Paul | Chief Financial Officer | A | Class A Common Stock | 12123 | $0.00 | 236,133.0000 | 0 | 5.41% | 0.00% |
| March 1, 2024 | Evolent Health, Inc. | $EVH | Johnson John Paul | Chief Financial Officer | F | Class A Common Stock | 11213 | $34.41 | 224,920.0000 | 0 | 4.75% | 0.00% |
| March 2, 2024 | Evolent Health, Inc. | $EVH | Johnson John Paul | Chief Financial Officer | F | Class A Common Stock | 9020 | $34.41 | 215,900.0000 | 0 | 4.01% | 0.00% |
| Feb. 22, 2024 | Evolent Health, Inc. | $EVH | Johnson John Paul | Chief Financial Officer | A | Class A Common Stock | 44000 | $0.00 | 244,016.0000 | 0 | 22.00% | 0.00% |
| Feb. 22, 2024 | Evolent Health, Inc. | $EVH | Johnson John Paul | Chief Financial Officer | F | Class A Common Stock | 20006 | $33.03 | 224,010.0000 | 0 | 8.20% | 0.00% |